Correlation Between Hansa Biopharma and Lidds AB
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Lidds AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Lidds AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Lidds AB, you can compare the effects of market volatilities on Hansa Biopharma and Lidds AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Lidds AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Lidds AB.
Diversification Opportunities for Hansa Biopharma and Lidds AB
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Hansa and Lidds is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Lidds AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lidds AB and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Lidds AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lidds AB has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Lidds AB go up and down completely randomly.
Pair Corralation between Hansa Biopharma and Lidds AB
Assuming the 90 days trading horizon Hansa Biopharma AB is expected to under-perform the Lidds AB. But the stock apears to be less risky and, when comparing its historical volatility, Hansa Biopharma AB is 4.16 times less risky than Lidds AB. The stock trades about -0.13 of its potential returns per unit of risk. The Lidds AB is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Lidds AB on September 1, 2024 and sell it today you would lose (4.00) from holding Lidds AB or give up 26.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Hansa Biopharma AB vs. Lidds AB
Performance |
| Timeline |
| Hansa Biopharma AB |
| Lidds AB |
Hansa Biopharma and Lidds AB Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hansa Biopharma and Lidds AB
The main advantage of trading using opposite Hansa Biopharma and Lidds AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Lidds AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lidds AB will offset losses from the drop in Lidds AB's long position.The idea behind Hansa Biopharma AB and Lidds AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Lidds AB vs. Cantargia AB | Lidds AB vs. BioArctic AB | Lidds AB vs. Oncopeptides AB | Lidds AB vs. Hansa Biopharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |